M1 Kliniken AG (XTER:M12) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:M12 M1 Kliniken AG XTER:M12
79 GF Score
Price €19.88
GF Value €11.23
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is M1 Kliniken AG Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


M1 Kliniken AG  (XTER:M12) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


M1 Kliniken AG Cyclically Adjusted PB Ratio Related Terms


M1 Kliniken AG Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for M1 Kliniken AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M1 Kliniken AG Cyclically Adjusted PB Ratio Chart

M1 Kliniken AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.11 2.21 2.91 2.99

M1 Kliniken AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.57 3.03 2.61 3.09 2.98

XTER:M12 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, M1 Kliniken AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M1 Kliniken AG Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's Cyclically Adjusted PB Ratio falls into.


XTER:M12
79GF Score
M1 Kliniken AG XTER:M12
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M1 Kliniken AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

M1 Kliniken AG's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, M1 Kliniken AG's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=8.085/129.3606*129.3606
=8.085

Current CPI (Dec25) = 129.3606.

M1 Kliniken AG Annual Data

Book Value per Share CPI Adj_Book
201612 2.017 101.217 2.578
201712 2.865 102.617 3.612
201812 3.642 104.217 4.521
201912 3.898 105.818 4.765
202012 6.207 105.518 7.610
202112 7.530 110.384 8.825
202212 7.811 119.345 8.467
202312 7.488 123.773 7.826
202412 7.234 127.041 7.366
202512 8.085 129.361 8.085

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is M1 Kliniken AG (XTER:M12) Overvalued in 2026?

Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued. The current stock price of €19.88 is trading 77% above its estimated GF Value™ of €11.23. GuruFocus considers M1 Kliniken AG to be Significantly Overvalued.

Key valuation signals for XTER:M12:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €11.23 vs. price of €19.88 (77% above fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the XTER:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


M1 Kliniken AG Business Description

Address Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
79GF Score

Get the complete analysis for XTER:M12

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.88
Price
€11.23
GF Value